2D |
Two-dimensional |
3D |
Three-dimensional |
AJCC |
American Joint Commission on Cancer |
AKT |
Protein kinase B |
BCL-2 |
B-cell lymphoma-2 |
BCL-XL |
B-cell lymphoma-extra large protein |
BRAF |
v-Raf murine sarcoma viral oncogene homolog B |
CDKN2A |
Cyclin-dependent kinase inhibitor 2A |
CTCs |
Circulating tumor cells |
ctDNA |
Circulating tumor DNA |
CTLA-4 |
T-lymphocyte-associated protein |
CT |
Computed tomography |
DDR |
DNA damage repair |
EMT |
Epithelial mesenchymal transition |
EpCAM |
Epithelial cell adhesion molecule |
ERK |
Extracellular Signal-Regulated Kinase |
FDA |
Food and Drug Administration |
HIF-1α |
Hypoxia-inducible factor-1α |
HiRIEF LC-MS/MS |
High-resolution isoelectric focusing liquid chromatography-mass spectrometry |
HR |
Homologous recombination |
ICI |
Immune checkpoint inhibitor |
IFN |
Interferon |
IL |
Interleukin |
IMPRES |
IMmuno-PREdictive Score |
ITS |
Immunotherapy score |
KIT |
v-kit Hardy–Zuckerman 4 feline sarcoma viral oncogene homolog |
LDH |
lactate dehydrogenase |
MAP3K |
Mitogen-activated protein kinase kinase |
MAPK |
Mitogen-activated protein kinase |
MCL-1 |
Myeloid leukemia cell differentiation |
MEK |
Mitogen-activated protein kinase kinase |
MHC |
Major histocompatibility complex |
miR |
microRNA |
MRI |
Magnetic Resonance Imaging |
NF1 |
Neurofibromin 1 |
NFκB |
Nuclear factor kappa-light-chain-enhancer of activated B cells |
NGS |
Next-generation-sequencing |
NL |
Neoantigen load |
NRAS |
Neuroblastoma RAS viral oncogene homolog |
OS |
Overall Survival |
PD1 |
Programmed cell death protein 1 |
PDL1 |
Programmed death-ligand 1 |
PEAs |
Proximity extension assays |
PFS |
Progression Free Survival |
PI3K |
Phosphoinositol-3-kinase |
PIP2 |
Phosphatidylinositol (4,5)-bisphosphate |
PIP3 |
Phosphatidylinositol (3,4,5)-trisphosphate |
PET |
Positron Emission Tomography |
PTEN |
Phosphatase and tensin homolog deleted on chromosome 10 |
RECIST |
Response Evaluation Criteria in Solid Tumours |
RFS |
Shorter relapse-free survival |
RNA-seq |
Fast RNA sequencing |
STAT3 |
Signal transducer and activation of transcription-3 |
TA |
Texture analysis |
TERC |
Telomerase RNA component |
TERT |
Telomerase reverse transcriptase |
TGF-β |
Transforming Growth Factor-β |
TILs |
Tumor-infiltrating lymphocytes |
TMB |
Tumor mutational burden |
VEGF |
Vascular endothelial growth factor |